Literature DB >> 7356645

Biosynthesis of murine terminal deoxynucleotidyltransferase.

A Silverstone, L Sun, O N Witte, D Baltimore.   

Abstract

An immunoprecipitation assay for measuring synthesis of murine terminal deoxynucleotidyltransferase (EC 2.7.7.31) has been developed using rabbit antiserum to calf terminal transferase. The antiserum precipitates a single Mr = 60,000 polypeptide (TdT-60) from all cell lines and tissues that contain enzymologically demonstrable terminal transferase. This polypeptide is not precipitated from labeled extracts of cells that lack terminal transferase by enzymological criteria. TdT-60 fractionates with terminal transferase during phosphocellulose chromatography and sediments with it in a sucrose gradient. TdT-60 is not detectably processed to lower molecular weight polypeptides, and terminal transferase activity sediments as a Mr = 60,000 activity; thus, we believe it to be the active form of terminal transferase. Using this assay we have demonstrated that terminal transferase is synthesized in both the murine thymus and the bone marrow at a rate proportional to its biochemically measured steady state level. After cortisone treatment of mice, the Mr = 60,000 polypeptide disappears from the thymus and then reappears as the thymus begins to be repopulated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7356645

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Rate of replication of the murine immunoglobulin heavy-chain locus: evidence that the region is part of a single replicon.

Authors:  E H Brown; M A Iqbal; S Stuart; K S Hatton; J Valinsky; C L Schildkraut
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

2.  Cloning of terminal transferase cDNA by antibody screening.

Authors:  N R Landau; T P St John; I L Weissman; S C Wolf; A E Silverstone; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

3.  Increased frequency of N-region insertion in a murine pre-B-cell line infected with a terminal deoxynucleotidyl transferase retroviral expression vector.

Authors:  N R Landau; D G Schatz; M Rosa; D Baltimore
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

4.  Activation of the fructose 1,6-bisphosphatase gene by 1,25-dihydroxyvitamin D3 during monocytic differentiation.

Authors:  D H Solomon; M C Raynal; G A Tejwani; Y E Cayre
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

5.  Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures.

Authors:  J C Young; O N Witte
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

6.  Adenosine deaminase messenger RNAs in lymphoblast cell lines derived from leukemic patients and patients with hereditary adenosine deaminase deficiency.

Authors:  G S Adrian; J J Hutton
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

7.  Replication of proto-oncogenes early during the S phase in mammalian cell lines.

Authors:  M A Iqbal; J Chinsky; V Didamo; C L Schildkraut
Journal:  Nucleic Acids Res       Date:  1987-01-12       Impact factor: 16.971

8.  In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.

Authors:  J McLaughlin; E Chianese; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

9.  Abelson virus-infected cells can exhibit restricted in vitro growth and low oncogenic potential.

Authors:  C A Whitlock; O N Witte
Journal:  J Virol       Date:  1981-11       Impact factor: 5.103

10.  PATZ1 Is a DNA Damage-Responsive Transcription Factor That Inhibits p53 Function.

Authors:  Nazli Keskin; Emre Deniz; Jitka Eryilmaz; Manolya Un; Tugce Batur; Tulin Ersahin; Rengul Cetin Atalay; Shinya Sakaguchi; Wilfried Ellmeier; Batu Erman
Journal:  Mol Cell Biol       Date:  2015-03-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.